By Bruce Carton2015-12-17T08:45:00
In recent weeks, Martin Shkreli, CEO of Turing Pharmaceuticals AG, has become the the “most hated man in America” for unapologetically raising the price of an important HIV-fighting drug from $13.50 to $750. It was with unbridled glee, then, that the media reported that Shkreli was arrested this morning on ...
You are not logged in and do not have access to members-only content.
If you are already a registered user or a member, SIGN IN now.
2016-12-06T11:30:00Z By Neil Hodge
How pharmaceutical firms price their products is getting a lot of additional attention in the United Kingdom and United States. Neil Hodge reports.
2026-01-13T20:05:00Z By Adrianne Appel
The U.S. Securities and Exchange Commission dropped its case against Rio Tinto’s former chief financial officer, who has battled charges for eight years.
2026-01-12T13:55:00Z By Adrianne Appel
The owner of a medical supply company allegedly billed federal health programs $30 million for items that were unnecessary and tainted by kickbacks, according to the Department of Justice (DOJ).
Site powered by Webvision Cloud